Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live

United States & Merck & Co.

7 shared events · Importance 6 · Last updated Jul 02, 2026

Importance
6
Shared Events
7
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
42
Tech
United States: The studies discussed involve patients and practices within the United States>>> and address a significant health concern for American women.
Merck & Co.: Merck & Co.>>>'s immunotherapy Keytruda is mentioned as potentially faring better when patients are also taking GLP-1 drugs, suggesting a possible interaction with the immune system.
Jun 02, 2026 · 45 articles
0
Domestic
Merck & Co.: Merck & Co., a hepatitis B vaccine maker, expressed deep concern over the ACIP's vote, and its shares closed down 1.2% on Friday.
Dec 05, 2025 · 7 articles
0
Regulatory
Merck & Co.: Merck & Co. struck a deal to cut prices, committing to sell its diabetes drugs Januvia, Janumet, and Janumet XR at 70% off list prices directly to US consumers and pledging $70 billion in US R&D and manufacturing investments.
Dec 19, 2025 · 7 articles
0
Business
Feb 03, 2026 · 6 articles
0
Domestic
Mar 16, 2026 · 22 articles
0
Regulatory
May 15, 2026 · 17 articles
0
Domestic
Apr 22, 2026 · 6 articles
NEWSDESK
Explore this relationship live

Track how United States and Merck & Co. interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.